A Study of ABT-199 (Venetoclax) for Cutaneous T Cell Lymphoma (CTCL)
Condition: CTCL Intervention: Drug: ABT-199 (venetoclax) Sponsor: Yale University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials